Home Tools
Log in
Cart

Search Result

Search Results for " checkpoint "

20

Compounds

Cat No. Product Name Synonyms Targets
T6093 AZD-7762 AZD7762 Chk
AZD-7762, an effective and specific inhibitor of Chk1(IC50=5 nM), is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck.
T5697 BMS-1166 PD-1/PD-L1
BMS-1166 is a potent PD-1/PD-L1 interaction inhibitor.
T7080 CCT245737 SRA737 Chk
CCT245737 (SRA737) is an orally active and selective Chk1 inhibitor (IC50: 1.3 nM); CCT245737 shows much less activity against Chk2 (IC50: 2440 nM).
T21331 SAR-020106 Chk
SAR-020106 is a potent, ATP-competitive, and selective CHK1 inhibitor with an IC50 of 13.3 nmol/L on the isolated human enzyme.
T10565 BMS-1001 hydrochloride PD-1/PD-L1
BMS-1001 hydrochloride is an orally active inhibitor of human PD-1/PD-L1 immune checkpoint with low-toxicity in cells.BMS-1001 alleviates the inhibitory effect of the soluble PD-L1 on the T-cell receptor-mediated activat...
T2517 SCH900776 MK 8776,MK-8776 Chk , CDK
SCH900776 (MK-8776) is an agent targeting cell cycle checkpoint kinase 1 (Chk1) with potential radiosensitization and chemosensitization activities.
T6350 CHIR-124 CHIR124,CHIR 124 Apoptosis , GSK-3 , FLT , Chk , PDGFR , Src
CHIR-124 is an effective Chk1 inhibitor (IC50: 0.3 nM). It has 2, 000-fold selectivity against Chk2, 500- to 5, 000-fold less activity against Cdc2 and CDK2/4.
T6084 Rabusertib LY2603618,IC-83 Chk , PDK , Autophagy
Rabusertib (IC-83) is an inhibitor of the cell cycle checkpoint kinase 1 (chk1) with potential chemopotentiating activity. Rabusertib has been used in trials studying the treatment of Cancer, Solid Tumors, Advanced Cance...
T2033 BML-277 C 3742,Chk2 Inhibitor II,BML 277 Apoptosis , Chk
BML-277 (C 3742) is a selective checkpoint kinase 2 (Chk2) inhibitor.
T7300 GDC-0575 ARRY-575,RG7741 Chk
GDC-0575 (ARRY-575) is a highly-selective oral small-molecule Chk1 inhibitor(IC50 of 1.2 nM).
T4327 Prexasertib dihydrochloride LY2606368 (dihydrochloride),Prexasertib HCl,LY2606368 Apoptosis , Chk , S6 Kinase
Prexasertib dihydrochloride (LY2606368) is an ATP-competitive CHK1 inhibitor (Ki: 0.9 nmol/L). in the cell-free assay, its IC50 values are 8 nM and 9 nM for CHK2 and RSK, respectively.
T4310 Prexasertib LY2606368 Apoptosis , Chk
Prexasertib (LY2606368) is an inhibitor of checkpoint kinase 1 (chk1) with potential antineoplastic activity.
T6028 PF 477736 PF 00477736,PF-477736,PF-736,PF-00477736,PF477736 c-Fms , VEGFR , FGFR , FLT , c-RET , Chk , CDK , Src , Aurora Kinase
PF 477736 (PF-736,PF-00477736) is a specifc, effective and ATP-competitive Chk1 inhibitor (Ki: 0.49 nM ) and also inhibits FGFR3, Aurora-A, VEGFR2, Flt3, Fms (CSF1R), Ret and Yes.
T2077 Adavosertib AZD1775,MK-1775,Adavosertib (MK-1775) Wee1
Adavosertib (MK-1775) is a small molecule inhibitor of the checkpoint kinase WEE1 (IC50: 5.2 nM). It hinders the G2 DNA damage checkpoint.
T9252 LY2880070 Chk
LY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
T10792L CHK1-IN-4 hydrochloride CHK1-IN-4 hydrochloride(2120398-41-4 Free base) Chk
CHK1-IN-4 hydrochloride is a potent inhibitor of checkpoint kinase 1 (chk1). CHK1-IN-4 hydrochloride potently inhibits chk1 phosphorylation in the tumor cells. CHK1-IN-4 hydrochloride has anti-tumor activity.
T10791 CHK1-IN-3 Chk
CHK1-IN-3 is an inhibitor of checkpoint kinase 1 (CHK1; IC50: 0.4 nM).
T10406 Tuvusertib M1774,ATR inhibitor 1 Apoptosis , ATM/ATR , Others , Chk
Tuvusertib (M1774) is an orally available ataxia telangiectasia and Rad3-related (ATR) kinase inhibitor (Ki< 1 µΜ) with selective and potentially antitumor activity.Tuvusertib selectively inhibits ATR activity and blocks...
T6931 PD0166285 PD-166285 Apoptosis , Wee1 , Chk
PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.
T14765 BOS-172722 Kinesin
BOS-172722 is an inhibitor of monopolar spindle 1 (MPS1) checkpoint(IC50 of 2 nM).
1 2 3 4 5
TargetMol